Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island, Indonesia

Filaria Journal

Volumn 4, Issue , 2005, Pages

  Oqueka, Tim ^a   Supali, Taniawati ^b   Ismid, Is Suhariah ^b   Purnomo, ^c   Rückert, Paul ^d   Bradley, Mark ^e   Fischer, Peter ^a,f  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^d German Technical Co operation   (Indonesia)

^e GLAXOSMITHKLINE   (United Kingdom)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE;

ADOLESCENT; ADULT; ARTICLE; ASCARIS LUMBRICOIDES; BLOOD FILTRATION; BRUGIA; BRUGIA TIMORI; CHILD; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG RESPONSE; FECES ANALYSIS; FEMALE; HEALTH PROGRAM; HELMINTHIASIS; HOOKWORM; HUMAN; INDONESIA; INFECTION CONTROL; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; MICROFILARIA; NEMATODIASIS; PREVALENCE; TREATMENT OUTCOME; TRICHURIS;

EID: 33645765416     PISSN: 14752883     EISSN: 14752883     Source Type: Journal    
DOI: 10.1186/1475-2883-4-5     Document Type: Article

References (39)

1. Bebehani K: Candidate parasitic diseases. Bull World Health Organ 1998, 76(Suppl):64-67.
2. Ottesen EA, Duke BO, Karam M, Behbehani K: Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997, 75:491-503.
3. Michael E, Bundy DA: Global mapping of lymphatic filariasis. Parasitol Today 1997, 13:472-476.
4. Molyneux D: Lymphatic filariasis (elephantiasis) elimination: a public health success and development opportunity. Filaria J 2003, 2:13.
5. Horton J, Witt C, Ottesen EA, Lazdins JK, Addiss DG, Awadzi K, Beach MJ, Belizario VY, Dunyo SK, Espinel M, Gyapong JO, Hossain M, Ismail MM, Jayakody RL, Lammie PJ, Makunde W, Richard-Lenoble D, Selve B, Shenoy RK, Simonsen PE, Wamae CN, Weerasooriya MV: An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 2000:147-160.
6. Shenoy RK, John A, Babu BS, Suma TK, Kumaraswami V: Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations. Ann Trop Med Parasitol 2000, 94:607-614.
7. Ramaiah KD, Vanamail P, Pani SP, Yuvaraj J, Das PK: The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination. Trop Med Int Health 2002, 9:767-774.
8. De Silva NR, Pathmeswaran A, Fernando SD, Weerasinghe CR, Padmasiri EA, Montressor A: Impact of mass chemotherapy for the control of filariasis on geohelminth infections in Sri Lanka. Ann Trop Med Parasitol 2003, 97:421-425.
9. Rajendran R, Mani TR, Munirathinam A, Sunish IP, Abdullah SM, Augustin DJ, Satyanarayana K: Sustainability of soil-transmitted helminth control following a single-dose co-administration of albendazole and diethylcarbamazine. Trans R Soc Trop Med Hyg 2003, 97:355-359.
10. Mani TR, Rajendran R, Munirathinam A, Sunish IP, Abdullah S, Augustin DJ, Satyanarayana K: Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India. Trop Med Int Health 2002, 7:541-548.
11. Mani TR, Rajendran R, Sunish IP, Munirathinam A, Arunachalam N, Satyanarayana K, Dash AP: Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme. Trop Med Int Health 2004, 9:1030-1035.
12. Partono F, Maizels RM, Purnomo: Towards a filariasis-free community: evaluation of filariasis control over an eleven year period in Flores, Indonesia. Trans R Soc Trop Med Hyg 1989, 83:821-826.
13. Supali T, Ismid I, Rückert P, Fischer P: Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae. Trop Med Int Health 2002, 7:894-901.
14. Fischer P, Djuardi Y, Ismid I, Rückert P, Bradley B, Supali T: Long-lasting reduction of Brugia timori microfilariae following a single dose of diethylcarbamazine combined with albendazole. Trans R Soc Trop Med Hyg 2003, 97:446-448.
15. Fischer P, Supali T, Maizels RM: Lymphatic filariasis and Brugia timori: prospects for elimination. Trends Parasitol 2004, 20:351-355.
16. Supali T, Wibowo H, Rückert P, Fischer K, Ismid I, Purnomo, Djuardi Y, Fischer P: High prevalence of Brugia timori infection in the highland of Alor island, Indonesia. Am J Trop Med Hyg 2002, 66:560-565.
17. Supali T, Rahmah N, Djuardi Y, Sartono E, Ruckert P, Fischer P: Detection of filaria specific IgG4 antibodies using Brugia Rapid test in individuals from an area highly endemic for Brugia timori. Acta Trop 2004, 90:255-261.
18. Fischer P, Wibowo H, Pischke S, Ruckert P, Liebau E, Ismid IS, Supali T: PCR-based detection and identification of the filarial parasite Brugia timori from Alor Island, Indonesia. Ann Trop Med Parasitol 2002, 96:809-821.
19. Krentel A, Rückert P, Servais G, Manoempil P, Fischer P: A knowledge, attitudes and practice (KAP) survey of lymphatic filariasis to prepare and evaluate mass drug administration in Alor District, Indonesia. in press.
20. Muller R: Worms and Human Disease 2nd edition. CABI Publishing, Wallingford, UK; 2002.
21. Molyneux DH, Hopkins DR, Zagaria N: Disease eradication, elimination and control: the need for accurate and consistent usage. Trends Parasitol 2004, 20:347-351.
22. Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW: Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med 2002, 347:1841-1848.
23. Bockarie MJ, Kazura KW: Lymphatic filariasis in Papua New Guinea: prospects for elimination. Med Microbiol Immunol 2003, 192:9-14.
24. Subramanian S, Stolk WA, Ramaiah KD, Plaisier AP, Krishnamoorthy K, Van Oortmarssen GJ, Dominic Amalraj D, Habbema JD, Das PK: The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology 2004, 128:467-482.
25. Burkot T, Ichimori K: The PacELF programme: will mass drug administration be enough? Trends Parasitol 2002, 18:109-115.
26. Joesoef A, Dennis DT: Intestinal and blood parasites of man on Alor Island Southeast Indonesia. Southeast Asian J Trop Med Public Health 1980, 11:43-47.
27. Higgins DA, Jenkins DJ, Kurniawan L, Purnomo, Harun S, Juwono SS: Human intestinal parasitism in three areas of Indonesia: a survey. Ann Trop Med Parasitol 1984, 78:637-648.
28. Horton J: Albendazole: a review of anthelminthic efficacy and safety in humans. Parasitlogy 2000:113-132.
29. Bennett A, Guyatt H: Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol Today 2000, 16:71-74.
30. Meyrowitsch DW, Simonsen PE: Short communication: efficacy of DEC against Ascaris and hookworm infections in schoolchildren. Trop Med Int Health 2001, 6:739-742.
31. Soeripto N: Reinfection and infection rates of soil-transmitted-helminths in Kemiri Sewu, Yogyakarta, Indonesia. Southeast Asian J Trop Med Public Health 1991, 22:216-221.
32. Ottesen EA, Ismail MM, Horton J: The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999, 15:382-386.
33. Turner P, Michael E: Recent advances in the control of lymphatic filariasis. Parasitol Today 1997, 13:410-411.
34. Belizario VY, Amarillo ME, de Leon WU, de los Reyes AE, Bugayong MG, Macatangay BJC: A comparison of the efficacy of single doses of albendazole, ivermectin and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. Bull World Health Organ 2003, 81:35-42.
35. Hall A, Anwar KS, Tomkins AM: Intensity of reinfection with Ascaris lumbricoides and its implications for parasite control. Lancet 1992, 339:1253-1257.
36. Hagel I, Lynch NR, Di Prisco MC, Perez M, Sanchez JE, Pereyra BN, Soto de Sanabria I: Helminth infection and anthropometric indicators in children from a tropical slum: Ascaris reinfection after anthelminthic treatment. J Trop Pediatr 1999, 45:215-220.
37. Ismail MM, Jayakody RL: Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka. Ann Trop Med Parasitol 1999, 93:501-504.
38. Pani SP, Subramanyam Reddy G, Das LK, Vanamail P, Hoti SL, Ramesh J, Das PK: Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate(DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study. Filaria J 2002, 1:1.
39. Hotez PJ, Zhan B, Bethony JM, Loukas A, Williamson A, Goud GN, Hawdon JM, Dobardzic A, Dobardzic R, Ghosh K, Bottazzi ME, Mendez S, Zook B, Wang Y, Liu S, Essiet-Gibson I, Chung-Debose S, Xiao S, Knox D, Meagher M, Inan M, Correa-Oliveira R, Vilk P, Shepherd HR, Brandt W, Russell PK: Progress in the development of a recombinant vaccine for human hookworm disease: the human hookworm vaccine initiative. Int J Parasitol 2003, 33:1245-1258.